Rapamycin mitigates warm ischemia-induced peribiliary fibrosis: A non-transplant experimental model with implications for ischemic cholangiopathy
Open Access
- 12 February 2026
- journal article
- Published by Korean Liver Transplantation Society in Annals of Liver Transplantation
- Vol. 6 (1) , 33-40
Abstract
Hyun Hwa Choi, Geun Hong, Kwang-Woong Lee, Jae-Yoon Kim, Jiyoung Kim, Jaewon Lee, Su Young Hong, Suk Kyun Hong, YoungRok Choi. Ann Liver Transplant -0001;0:. https://doi.org/10.52604/alt.25.0022Keywords
Funding Information
- Seoul National University (800-20110414)
This publication has 21 references indexed in Scilit:
- Research progress of mTOR inhibitorsEuropean Journal of Medicinal Chemistry, 2020
- Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ TransplantationDrug Safety, 2019
- Post-transplant cholangiopathy: Classification, pathogenesis, and preventive strategiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Early Biliary complications after liver transplantationClinical Liver Disease, 2017
- Longterm results of liver transplantation from donation after circulatory deathLiver Transplantation, 2016
- Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary stricturesJournal of Hepatology, 2014
- Events in Procurement as Risk Factors for Ischemic Cholangiopathy in Liver Transplantation Using Donation After Cardiac Death DonorsLiver Transplantation, 2011
- Rapamycin inhibits cholangiocyte regeneration by blocking interleukin-6–induced activation of signal transducer and activator of transcription 3 after liver transplantationLiver Transplantation, 2010
- Rapamycin and tacrolimus differentially modulate acute graft-versus-host disease in rats after liver transplantationLiver Transplantation, 2009
- Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosisJournal of Hepatology, 2006